Skip to main content
. Author manuscript; available in PMC: 2015 Dec 2.
Published in final edited form as: Circ Heart Fail. 2010 Jan 27;3(2):220–227. doi: 10.1161/CIRCHEARTFAILURE.109.903153

Table 1.

Clinical Characteristics of 756 Subjects in the Penn Heart Failure Study According to ProBNP1-108 Tertile

Entire Cohort (n=756) Tertile 1 (5–107 pg/ml) (n=252) Tertile 2 (108–572 pg/ml) (n=252) Tertile 3 (>572 pg/ml) (n=252) p value*
Mean age, yrs (s.d.) 57 (14) 51 (13) 58 (14) 60 (14) <0.001
Male, n (%) 522 (69) 161 (64) 176 (70) 185 (73) 0.07
Race
Caucasian, n (%) 617 (82) 206 (82) 204 (82) 207 (83) 0.97
African American 105 (14) 35 (14) 34 (14) 36 (14)
Other 28 (4) 9 (4) 11 (4) 8 (3)
Tobacco Use
 Never, n (%) 279 (37) 108 (43) 75 (30) 96 (38) 0.008
 Former 428 (57) 124 (49) 158 (63) 146 (58)
 Current 49 (6) 20 (8) 19 (7) 10 (4)
Hypertension History, n (%) 360 (48) 103 (41) 121 (48) 136 (54) 0.01
Diabetes History, n (%) 210 (28) 48 (19) 86 (34) 76 (30) <0.001
Mean creatinine, mg/dL (s.d.) 1.3 (0.7) 1.1 (0.3) 1.2 (0.5) 1.5 (1.0) <0.001
Mean body mass Index, kg/m2 (s.d.) 29 (6) 30 (7) 30 (7) 28 (7) 0.34
Mean SBP, mmHg (s.d.) 113 (19) 116 (16) 115 (17) 109 (21) <0.001
Cardiomyopathy Etiology Ischemic, n (%) 250 (33) 31 (12) 102 (40) 117 (46) <0.001
Heart Failure Type Diastolic, n (%) 94 (12) 47 (50) 25 (27) 22 (23) 0.01
NYHA
 I, n (%) 115 (15) 77 (31) 31 (12) 7 (3) <0.001
 II 330 (44) 129 (51) 115 (46) 86 (34)
 III 222 (29) 41 (16) 82 (33) 99 (39)
 IV 89 (12) 5 (2) 24 (9) 60 (24)
EF, mean (s.d.) 32 (16) 41 (14) 30 (15) 24 (16) <0.001
Cardiac Resynchronization, n (%) 208 (28) 38 (15) 74 (29) 96 (38) <0.001
Ace-inhibitor or ARB, n (%) 648 (86) 227 (90) 225 (89) 196 (78) 0.001
Beta blocker, n (%) 626 (83) 210 (83) 214 (85) 202 (80) 0.35
Mean BNP32, pg/ml (s.d.) 327 (509) 33 (47) 154 (106) 794 (657) <0.001
*

ANOVA for continuous variables; Chi-square test for categorical